NEW YORK , April 14, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Medifast, Inc. (NYSE: MED) on behalf of the company's shareholders. The investigation seeks...
3 Consumer Stocks That Concern Us
3 of Wall Street’s Favorite Stocks We Steer Clear Of
3 Reasons MED is Risky and 1 Stock to Buy Instead
1 Small-Cap Stock with Exciting Potential and 2 We Find Risky
Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
Company Agrees to Nominate Parsa Kiai and Jeff Rose as Director Candidates at 2026 Annual Meeting of Stockholders
3 Out-of-Favor Stocks with Open Questions
Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions
As part of its continued focus on improving metabolic health, Medifast ® (NYSE: MED) today announced that OPTA VIA ’s comprehensive metabolic...